Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
| EXAIDelisted Stock | USD 4.84 0.00 0.00% |
Under 61% of Exscientia's investor base is looking to short. The analysis of overall sentiment of trading Exscientia Ltd ADR stock suggests that many investors are alarmed at this time. Exscientia's investing sentiment shows overall attitude of investors towards Exscientia Ltd ADR.
Exscientia |
Exscientia plc today announced three abstracts to be presented at the 36th EORTC-NCI-AACR Symposium 2024 from October 23-25, in B
Read at businesswire.com
 |
Exscientia Fundamental Analysis
We analyze Exscientia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exscientia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exscientia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
Exscientia is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Exscientia ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Exscientia stock to make a market-neutral strategy. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics with similar companies.
Peers
Exscientia Related Equities
| LPTX | Leap Therapeutics | 5.16 | ||||
| IPSC | Century Therapeutics | 3.85 | ||||
| ELEV | Elevation Oncology | 3.28 | ||||
| RVMD | Revolution Medicines | 1.97 | ||||
| UBX | Unity Biotechnology | 1.68 | ||||
| GLUE | Monte Rosa | 1.65 | ||||
| PIRS | Pieris Pharmaceuticals | 1.37 | ||||
| BPMC | Blueprint Medicines | 0.81 | ||||
| MREO | Mereo BioPharma | 0.59 | ||||
| SANA | Sana Biotechnology | 1.21 | ||||
| ZURA | Zura Bio | 1.63 | ||||
| RXRX | Recursion Pharmaceuticals | 1.83 | ||||
| RLAY | Relay Therapeutics | 2.06 | ||||
| KYMR | Kymera Therapeutics | 2.21 | ||||
| PDSB | PDS Biotechnology | 2.76 | ||||
| ADAP | Adaptimmune Therapeutics | 2.86 | ||||
| AVIR | Atea Pharmaceuticals | 2.94 |
Check out Exscientia Hype Analysis, Exscientia Correlation and Exscientia Performance. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |